Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control

por Zappe, Dion, Papst, Cheraz Cherif, Ferber, Philippe
Publicado 2009

Time of administration important? Morning versus evening dosing of valsartan

por Zappe, Dion H., Crikelair, Nora, Kandra, Albert, Palatini, Paolo
Publicado 2015

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

por Anand, Inder S, Deswal, Anita, Kereiakes, Dean J, Purkayastha, Das, Zappe, Dion H
Publicado 2010

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly...

por Williams, Bryan, Cockcroft, John R, Kario, Kazuomi, Zappe, Dion H, Cardenas, Pamela, Hester, Allen, Brunel, Patrick, Zhang, Jack
Publicado 2014

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

por Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Publicado 2018

The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study

por Balp, Maria-Magdalena, Krieger, Nancy, Przybysz, Raymond, Way, Nate, Cai, Jennifer, Zappe, Dion, McKenna, Sarah Jane, Wall, Garth, Janssens, Nico, Tapper, Elliot
Publicado 2019

The burden of nonalcoholic steatohepatitis (NASH) in the United States

por Tapper, Elliot B., Krieger, Nancy, Przybysz, Raymond, Way, Nate, Cai, Jennifer, Zappe, Dion, McKenna, Sarah Jane, Wall, Garth, Janssens, Nico, Balp, Maria-Magdalena
Publicado 2023